Molecular Cytogenetics involves the study of chromosomes using
molecular biology to understand the role and functions of genes and
chromosomes. It plays a crucial role in the early diagnosis of a
disease, identification of genetic tendency to cause disease, and
prediction of an individual’s reaction to drugs. The FISH and aCGH play a
prominent role in molecular cytogenetics technology. It involves the
screening and diagnostic tests that are used for determining the complex
interaction of genes and chromosomes to assess the status of a disease.
In addition, molecular cytogenetics is mainly used in the R&D
activities of research laboratories for drug discovery, identification
of biomarkers, and screening drug candidates that react to these
biomarkers. Analysts forecast the Global Molecular Cytogenetics Market will grow at a CAGR of 23.51 percent over the period 2013-2018.
The
Report recognizes the following companies as the key players in Global
Molecular Cytogenetics Market : Abbott Laboratories , Affymetrix Inc. ,
Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Illumina Inc.,
PerkinElmer Inc., Applied Spectral Imaging Ltd, Biological Industries
Ltd, Bio-Rad Laboratories Inc., Cytognomix Inc., CytoTest Inc., Illumina
Inc., Kreatech Inc. , Leica Biosystems Ltd, Life Technologies Corp.,
Oxford Gene Technology Ltd, SciGene Corp.
Molecular cytogenetic
techniques can be used in personalized medicines for the early detection
of diseases and selection of appropriate treatment, integration of
molecular diagnostics with therapeutics, and monitoring therapy, as well
as determining the prognosis. At present, cytogenetic analysis allows
the study of essential biological problems such as the nature of
inherited syndromes and genomic variations, which are responsible for
carcinogenesis and 3D organization of the human genome. Identification
and validation of the genetic composition of an individual plays a major
part in ascertaining health and susceptibility to common diseases such
as heart disease and cancer. The awareness of genetic diseases is
helping in the development of personalized medicines, which are focused
on targeted drug development. Genetic profiling of patients helps in
defining an individual's risk for clinical outcomes and his/her response
to specific drugs. Personalized medicines are highly effective and help
improve the health of a patient.
Covered in this Report
This
report covers the present scenario and the growth prospects of the
Global Molecular Cytogenetics market for the period 2014-2018. To
calculate the market size, the report considers revenue generated from
the sales of products used in molecular cytogenetics. The products
employed in the use of FISH and aCGH techniques are considered within
the
Scope of the report
Global Molecular
Cytogenetics Market 2014-2018, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the
Americas, and the EMEA and APAC regions with individual country-wise
revenue segmentation; it also covers the Global Molecular Cytogenetics
market landscape and its growth prospects in the coming years. The
report also includes a share of the key vendors operating in this
market.
According to the report, the increase in the incidence of
genetic disorders is one of the major drivers. Genetic disorders such as
Down syndrome, fragile X syndrome, tuberous sclerosis, and other
genetic and chromosomal disorders have increased the demand for
cytogenetic diagnostic kits and technology.
Further, the report
states that one of the major challenges in the market is the lack of
knowledge about genomics among doctors and researchers, which leads to
misinterpretation of the genetic data of an individual.
